期刊文献+

阿魏酸钠对糖尿病大鼠肾脏的保护机制 被引量:1

Protection mechanism of sodium ferulate on diabetic rats' kidney
原文传递
导出
摘要 目的:探讨阿魏酸钠对糖尿病大鼠肾脏的保护机制。方法:50只雄性SD大鼠随机分为2组,正常对照组10只,造模组40只。造模组采用空腹一次性尾静脉注射链脲佐菌素(STZ)55mg/kg制造糖尿病模型,72小时后血糖≥16.7mmol/l为造模成功。将造模成功的40只大鼠随机分为糖尿病模型组、阿魏酸钠50mg/kg、100mg/kg、200mg/kg,给药8周后全自动化生化分析仪检测生化指标,免疫组化法和Western Blot法检测转化生长因子-β1(TGF-β1)、Smad1、Ⅳ型胶原(ColⅣ)定位和半定量表达,电镜观察肾脏组织超微结构。结果:与糖尿病模型组相比,阿魏酸钠高中低剂量组基底膜增厚、系膜基质积聚、足突融合均减轻,肾脏组织中TGF-β1、Smad1、ColⅣ表达减少,且有剂量依赖性,高剂量组改变最明显。结论:阿魏酸钠对糖尿病肾脏具有保护作用,可能与降低TGF-β1、Smad1、ColⅣ的表达有关。 Objiective: To study the protection mechanism of sodium ferulate(SF) on diabetic rats' kidney.Methods : 50 male SD rats were randomly allocated into 2 groups: normal control group(n = 10),modle group(n = 40).Rats in the modle group were administered with strepto-zotocin(55mg/kg) by vena caudalis injection to induce diabetic model.The modle diabetes mellitus were considered to be successful when the concentration of blood glucose was constantly ≥16.7mmol/l 72 hours after the injection.The modle rats were divided randomly into 4 groups: diabetes mellitus modle group(n = 10),SF high dosages treatment group(n = 10),SF middle dosages treatment group(n = 10) and SF low dosages treatment group(n = 10).The latter 3 groups were given corresponding dosages of 50mg /(kg.d),100mg /(kg.d) and 200mg /(kg.d).The interference lasted for 8 weeks.Biochemical indices were obtained by automatic analyzer.Immunohistochemical method and Western Blotting analysis were used to detect the protein expression of smad1 and transforming growth factor-β1(TGF-β1),type Ⅳcollagen(Col Ⅳ).The Renal ultrastructure was observed by electron microscope.Results: Comparing with diabetes modle group,SF high,middle and low groups can reduce the expansion of mesangial matrix and thickening of the glomerular basement membrane,downgrade the expression of Smad1,TGF-β1 and ColⅣwith dosages-response relationship.SF high group changes more obvious.Conclusion: SF on diabetic kidney may have a protective effect.The mechanism may relate with reducing the expressing of TGF-β1,Smad1 andColⅣ.
出处 《中药药理与临床》 CAS CSCD 北大核心 2013年第1期57-60,共4页 Pharmacology and Clinics of Chinese Materia Medica
关键词 阿魏酸钠 糖尿病 肾脏 转化生长因子-Β1 SMAD1 Ⅳ型胶原 odium ferulate(阿魏酸钠) diabetes mellitus kidney transforming growth factor-β1 smad1 type Ⅳcollagen
  • 相关文献

参考文献9

  • 1赵同峰,张梁,邓华聪.阿魏酸钠对糖尿病大鼠肾脏的保护作用及机制研究[J].中国中西医结合杂志,2004,24(5):445-449. 被引量:41
  • 2Yu HT.Progression of the chronic renal failure.Arch Zntern Med,2003;163(12):1417-1429.
  • 3Li JH,Huang XR.Role of TGF-beta signaling in extracellular matrix pro-duction under high glucose conditions.Kidny Int,2003;63(6):2010-2019.
  • 4Chen S,Iglesias-dela MC,Jim B,et al.Reversibility of established dia-betic glomerulopathy by anti-TGF-beta antibodies in db/db mice.Bio-chem Biophys Res Commun,2003;300(1):16-22.
  • 5Oh SP,Seki T,Goss KA,et al.Activin receptor like kinase 1 modulatestransforming growth factor-β1 signaling in the regulation of angiogenesis.Proc Natl Acad Sci USA,2000;97(6):2626-2631.
  • 6Araoka T,Abe H,Tominaga T,et a1.Transcription factor7-like2(TCF7L2)regulates activin receptor-like kinase 1(ALK1)/smad1 pathwayfor development of diabetic nephropathway.Molecules and Cells,2010;30(2):209-218.
  • 7Huang S,Flanders KC,Roberts AB.Characterization of the mousesmad1 gene and its expression pattern in adult mouse tissues.Gene,2000;258(1-2):43-53.
  • 8Abe H,Matsubara T,Lehara N.TypeⅣcollagen is transcriptionally reg-ulated by smad1 under advanced glycation end product(AGE)stimulation.The Journal of Biological Chemistry,2004;279(14):14201-14206.
  • 9王锋,汪国贵,葛卫红,李晓萍,邬云红,袁启远,李婷,吴红梅,孙红娟.阿魏酸钠治疗糖尿病肾损害的系统评价[J].中国循证医学杂志,2009,9(6):652-669. 被引量:4

二级参考文献53

共引文献43

同被引文献14

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部